中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
22期
80-81,82
,共3页
洛铂%顺铂%香菇多糖%恶性胸腔积液
洛鉑%順鉑%香菇多糖%噁性胸腔積液
락박%순박%향고다당%악성흉강적액
Lobaplatin%Cisplatin%Lentinan%Malignant pleural effusion
目的:观察胸腔内置管注入洛铂和香菇多糖治疗恶性胸腔积液的疗效。方法:收治恶性胸腔积液60例,随机数字表法分为两组,经皮胸腔内置管引流尽胸液后,治疗组30例予胸腔内注入洛铂50 mg+香菇多糖4 mg,对照组30例予顺铂40 mg/m2注入胸腔。结果:治疗组总有效率和生活质量改善率均优于对照组(P<0.05)。两组毒副作用相近。结论:洛铂联合香菇多糖胸腔内化疗治疗恶性胸腔积液安全有效。
目的:觀察胸腔內置管註入洛鉑和香菇多糖治療噁性胸腔積液的療效。方法:收治噁性胸腔積液60例,隨機數字錶法分為兩組,經皮胸腔內置管引流儘胸液後,治療組30例予胸腔內註入洛鉑50 mg+香菇多糖4 mg,對照組30例予順鉑40 mg/m2註入胸腔。結果:治療組總有效率和生活質量改善率均優于對照組(P<0.05)。兩組毒副作用相近。結論:洛鉑聯閤香菇多糖胸腔內化療治療噁性胸腔積液安全有效。
목적:관찰흉강내치관주입락박화향고다당치료악성흉강적액적료효。방법:수치악성흉강적액60례,수궤수자표법분위량조,경피흉강내치관인류진흉액후,치료조30례여흉강내주입락박50 mg+향고다당4 mg,대조조30례여순박40 mg/m2주입흉강。결과:치료조총유효솔화생활질량개선솔균우우대조조(P<0.05)。량조독부작용상근。결론:락박연합향고다당흉강내화료치료악성흉강적액안전유효。
To observe lobaplatin the effectiveness and adverse reaction in the treatment of malignant pleural effusion by injection to thoracic cavity with lentinan combined with lobaplatin or cisplatin alone. Method:60 patients with malignant pleural effusion were divided into two groups,percutaneous intrathoracic drainage to pleural effusion,30 cases in the treatment group were treated with intrapleural injection of lobaplatin 50 mg+lentinan 4 mg, 30 cases in the control group treated with cisplatin 40 mg /m2 was injected into the pleural cavity. Result:The total effective rate and the improvement rate of life quality was better than that of the control group,with significant differences (P<0.05). The two groups had similar side effects. Conclusion:Chest tube rows of lobaplatin combined with mushrooms polysaccharide perfusion is safe and effective in the treatment of malignant pleural effusion,operation is convenient, effective,less adverse reactions,especially suitable for patients with advanced cancer through multiple platinum chemotherapy with pleural effusion.